β–adrenergic blockade, a renal perspective
dc.contributor.author | McLigeyo, Seth | |
dc.contributor.other | Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya) | en |
dc.date.accessioned | 2007-11-19T22:54:54Z | |
dc.date.available | 2007-11-19T22:54:54Z | |
dc.date.issued | 2007 | |
dc.description.abstract | Carvedilol • Third generation β–blocker (both β1and β2) • Possesses α1–adrenergic blocking properties. • β: αblocking ratio 7:1 to 3:1 • Antioxidant • Calcium antagonist | en |
dc.identifier.uri | https://hdl.handle.net/1805/1172 | |
dc.language | English | en |
dc.language.iso | en | en |
dc.publisher | Association of Kenya Physicians | en |
dc.subject | carvedilol | en |
dc.subject | myocardial function | en |
dc.subject | β-blockers | en |
dc.subject | hypertension | en |
dc.subject | anti-inflammatory | en |
dc.subject | diabetes | en |
dc.subject | GEMINI trial | en |
dc.subject.mesh | Adrenergic beta-Antagonists | |
dc.subject.mesh | carvedilol | |
dc.subject.mesh | nebivolol | |
dc.subject.mesh | Diabetes Mellitus drug therapy | |
dc.title | β–adrenergic blockade, a renal perspective | en |
dc.type | Presentation | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Beta blockade a renal perspective Prof Mccligeyo.pdf
- Size:
- 6.2 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.93 KB
- Format:
- Item-specific license agreed upon to submission
- Description: